AFRM vs CAI · P/E 590, rev $3.22B vs rev $216.8M
Affirm Holdings Inc (AFRM) versus Caris Life Sciences, Inc. Common Stock (CAI) — a side-by-side from cached financials, not a winner call.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
Caris Life Sciences, Inc. Common Stock (CAI) is a biotechnology company listed on NASDAQ.
Latest reported AFRM revenue for 2025-06-30 was $3.22B. Net income was $52.2M. Revenue was up 38.8% from 2024-06-30 to 2025-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
Latest reported CAI revenue for 2025-09-30 was $216.8M. Net income was $24.3M. Revenue was up 19.5% from 2025-06-30 to 2025-09-30. CAI currently screens at market cap $5.22B.
AFRM currently screens at market cap $28.80B and trailing P/E 589.7. CAI currently screens at market cap $5.22B.
Not investment advice. Open the AFRM and CAI stock pages for the full models.
Not investment advice.